论文部分内容阅读
山西瑞福莱药业有限公司利用现代科学的先进技术,有效地提取了银杏叶所含有的银杏黄酮、银杏苦内酯、银杏素等有效成份。该药研制成功之后,经过了山医一院、山医二院等多名专家教授的临床药理实验,结果表明,舒血宁片在心脑血管疾病治疗中疗效显著。舒血宁片的临床结果突出地表现在以下几个方面: ①对于急性缺血性脑血管病,舒血宁片能明显改善血液流变性,降低血脂,纤维蛋白原,改善红细胞性能。②影响血液流变学的6项指标说明它有明
Shanxi Rui Fu Lai Pharmaceutical Co., Ltd. uses modern science and advanced technology to effectively extract the effective ingredients of ginkgo flavonoids, ginkgolides, ginkgo biloba and so on. After the drug was successfully developed, it passed clinical pharmacological experiments conducted by a number of experts from the First Hospital of Shanxi Academy of Medicine and the Second Hospital of Shanxi Medicine. The results showed that Shuxuening tablet has a significant effect in the treatment of cardiovascular and cerebrovascular diseases. The clinical results of Shuxuening tablets are prominently demonstrated in the following aspects: 1 For acute ischemic cerebrovascular disease, Shuxuening tablet can significantly improve blood rheology, lower blood lipids, fibrinogen, and improve red blood cell performance. 2 The 6 indicators affecting hemorheology indicate that it is clear